Associate Professor Michael Barras
Conjoint Associate Professor (Princess Alexandra Hospital)
School of Pharmacy
Book Chapters
Barras, Michael (2015). Peri-procedural anticoagulation. Anticoagulation management: a guide for pharmacists . (pp. 179-199) edited by Anne Rose. Cham, Switzerland: Springer International Publishing. doi: 10.1007/978-3-319-22602-6_8
Barras, Michael and Green, Bruce (2009). Dose individualization of drugs based on body composition. Heart disease in men. (pp. 219-242) edited by Alice B. Todd and Margo H. Mosley. New York, NY, United States: Nova Science Publishers.
Journal Articles
van Oosterom, Nameer, Barras, Michael, Bird, Robert, Nusem, Iulian and Cottrell, Neil (2020). A narrative review of aspirin resistance in VTE prophylaxis for orthopaedic surgery. Drugs, 80 (18), 1889-1899. doi: 10.1007/s40265-020-01413-w
Falconer, Nazanin, Barras, Michael, Abdel‐Hafez, Ahmad, Radburn, Sam and Cottrell, Neil (2020). Development and validation of the Adverse Inpatient Medication Event Model (AIME). British Journal of Clinical Pharmacology bcp.14560. doi: 10.1111/bcp.14560
Snoswell, Centaine, Jensen, Estelle, Wang, Nancy, Shah, Krishna, Currey, Elizabeth and Barras, Michael (2020). Transit Care Hub pharmacist: improving patient flow within the hospital. International journal of clinical pharmacy, 42 (5), 1319-1325. doi: 10.1007/s11096-020-01092-3
Forrester, Tori G., Sullivan, Sara, Snoswell, Centaine L., Pillans, Peter, Barras, Michael and Sturgess, David (2020). Integrating a pharmacist into the perioperative setting. Australian Health Review, 44 (4), 563-568. doi: 10.1071/ah19126
George, Christopher, Barras, Michael, Coombes, Judith and Winckel, Karl (2020). Unfractionated heparin dosing in obese patients. International Journal of Clinical Pharmacy, 42 (2), 462-473. doi: 10.1007/s11096-020-01004-5
Austin, Jodie, Barras, Michael and Sullivan, Clair (2020). Interventions designed to improve the safety and quality of therapeutic anticoagulation in an inpatient electronic medical record. International Journal of Medical Informatics, 135 104066, 104066. doi: 10.1016/j.ijmedinf.2019.104066
van Oosterom, Nameer, Winckel, Karl and Barras, Michael (2020). Comment on: “Stratifying therapeutic enoxaparin dose in morbidly obese patients by BMI class: a retrospective cohort study”. Clinical Drug Investigation, 40 (3), 287-288. doi: 10.1007/s40261-020-00889-4
Banks, Vivien L., Barras, Michael and Snoswell, Centaine L. (2020). Economic benefits of pharmacy technicians practicing at advanced scope: a systematic review. Research in Social and Administrative Pharmacy, 16 (10), 1344-1353. doi: 10.1016/j.sapharm.2020.01.007
Falconer, Nazanin, Spinewine, Anne, Doogue, Matthew P. and Barras, Michael (2020). Identifying medication harm in hospitalised patients: a bimodal, targeted approach. Therapeutic Advances in Drug Safety, 11, 2042098620975516. doi: 10.1177/2042098620975516
Mohamed, Raafat, Cao, Yingnan, Afroz, Rizwana, Xu, Suowen, Ta, Hang T., Barras, Michael, Zheng, Wenhua, Little, Peter J. and Kamato, Danielle (2020). ROS directly activates transforming growth factor β type 1 receptor signalling in human vascular smooth muscle cells. Biochimica et Biophysica Acta. General Subjects, 1864 (1) 129463, 129463. doi: 10.1016/j.bbagen.2019.129463
Frazer, Andrew, Rowland, James, Mudge, Alison, Barras, Michael, Martin, Jennifer and Donovan, Peter (2019). Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients. European Journal of Clinical Pharmacology, 75 (12), 1645-1657. doi: 10.1007/s00228-019-02752-8
Snoswell, Centaine L., Skopp, Tom V. and Barras, Michael (2019). Quantifying pharmacist involvement in care for patients who experience multiple ward transitions. Pharmacy Growth, Research, Innovation and Training (Pharmacy GRIT), 3 (3) doi: 10.24080/grit.1202, 209-210.
Banks, Vivien L., Barras, Michael and Snoswell, Centaine L. (2019). Pharmacy technicians practicing in advanced scope roles. Pharmacy Growth, Research, Innovation and Training (Pharmacy GRIT), 3 (3) doi:10.24080/grit.1200, 174-177.
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2019). How hospital pharmacists prioritise patients at high-risk for medication harm. Research in Social and Administrative Pharmacy, 15 (10), 1266-1273. doi: 10.1016/j.sapharm.2018.11.003
Chevalier, Bernadette, Watson, Bernadette M., Barras, Michael A. and Cottrell, William N. (2019). Developing preliminary steps in a pharmacist communication - patient outcome pathway. Canadian Journal of Hospital Pharmacy, 72 (4), 271-281. doi: 10.4212/cjhp.v72i4.2913
van Oosterom, Nameer, Winckel, Karl and Barras, Michael (2019). Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity. Journal of Thrombosis and Thrombolysis, 48 (3), 387-393. doi: 10.1007/s11239-019-01847-4
Lukin, Bill, Greenslade, Jaimi, Kearney, Alison Mary, Douglas, Carol, Howell, Tegwen, Barras, Michael and Good, Phillip (2019). Conversion of other opioids to methadone: a retrospective comparison of two methods. BMJ Supportive and Palliative Care, 10 (2), bmjspcare-2018. doi: 10.1136/bmjspcare-2018-001645
Falconer, Nazanin, Barras, Michael, Martin, Jennifer and Cottrell, Neil (2019). Defining and classifying terminology for medication harm: a call for consensus. European Journal of Clinical Pharmacology, 75 (2), 137-145. doi: 10.1007/s00228-018-2567-5
Barras, M.A. and Winckel, K. (2019). Primary and secondary prevention of stroke. Australian Pharmacist, 12, 42-51.
Steel, L., Faint, A., Barras, M., Cottrell, N., Parnell, M., Macey, B. and Yip, H. (2019). NOAC's it's time to extenuate patient knowledge gaps. Heart, Lung and Circulation, 28, S221-S221. doi: 10.1016/j.hlc.2019.06.204
Donagher, Joni and Barras, Michael A. (2018). Therapeutic drug monitoring: using Bayesian methods to evaluate hospital practice. Journal of Pharmacy Practice and Research, 48 (6), 522-529. doi: 10.1002/jppr.1432
Scott, Ian A., Pillans, Peter I., Barras, Michael and Morris, Christopher (2018). Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review. Therapeutic Advances in Drug Safety, 9 (9), 559-573. doi: 10.1177/2042098618784809
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2018). Reply to Iuga and Genaidy "Comment on Falconer et al. (2018) - the need for specific adverse drug reaction outcomes". British Journal of Clinical Pharmacology, 84 (8), 1857-1857. doi: 10.1111/bcp.13633
Nafisa, Asma, Gray, Susan G., Cao, Yingnan, Wang, Tinghuai, Xu, Suowen, Wattoo, Feroza H., Barras, Michael, Cohen, Neale, Kamato, Danielle and Little, Peter J. (2018). Endothelial function and dysfunction: impact of metformin. Pharmacology and Therapeutics, 192, 150-162. doi: 10.1016/j.pharmthera.2018.07.007
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A., Cottrell, William N. and Angus, Daniel J. (2018). Using Discursis to enhance the qualitative analysis of hospital pharmacist-patient interactions. PLoS One, 13 (5) e0197288, e0197288. doi: 10.1371/journal.pone.0197288
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2018). Systematic review of predictive risk models for adverse drug events in hospitalised patients. British journal of clinical pharmacology, 84 (5), 846-864. doi: 10.1111/bcp.13514
Gao, Yanhua, Hennig, Stefanie and Barras, Michael (2018). Monitoring of tobramycin exposure: what is the best estimation method and sampling time for clinical practice?. Clinical Pharmacokinetics, 58 (3), 389-399. doi: 10.1007/s40262-018-0707-9
Gao, Yanhua, Barras, Michael and Hennig, Stefanie (2017). Bayesian estimation of tobramycin exposure in patients with cystic fibrosis — an update. Antimicrobial Agents and Chemotherapy, 62 (3) e01972, e01972-17. doi: 10.1128/AAC.01972-17
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William N. (2017). Hospital pharmacists’ and patients’ views about what constitutes effective communication between pharmacists and patients. International Journal of Pharmacy Practice, 26 (5), 450-457. doi: 10.1111/ijpp.12423
Barras, M.A. (2017). A word to the wise. Pharmacy GRIT, Autumn, 16-18.
Donagher, Joni, Martin, Jennifer H. and Barras, Michael A. (2017). Individualised medicine: why we need Bayesian dosing. Internal Medicine Journal, 47 (5), 593-600. doi: 10.1111/imj.13412
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neil (2017). Investigating strategies used by hospital pharmacists to effectively communicate with patients during medication counselling. Health Expectations, 20 (5), 1121-1132. doi: 10.1111/hex.12558
Paradissis, Chariclia, Coombes, Ian D., Donovan, Peter, Doran, Elizabeth, Mckean, Mitchell and Barras, Michael A. (2017). The type and incidence of adverse drug events in ageing medical inpatients and their effect on length of hospital stay. Journal of Pharmacy Practice and Research, 47 (5), 347-354. doi: 10.1002/jppr.1255
Barras, Michael and Legg, Amy (2017). Drug dosing in obese adults. Australian Prescriber, 40 (5), 189-193. doi: 10.18773/austprescr.2017.053
Barras, Michael A., Serisier, David, Hennig, Stefanie, Jess, Katrina and Norris, Ross L. G. (2016). Bayesian estimation of tobramycin exposure in cystic fibrosis. Antimicrobial Agents and Chemotherapy, 60 (11), 6698-6702. doi: 10.1128/AAC.01131-16
Nakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P. and Kennedy, Glen A. (2016). A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation. Supportive Care in Cancer, 25 (2), 1-7. doi: 10.1007/s00520-016-3445-2
Snoswell, Centaine and Barras, Michael (2016). Inpatient smoking cessation – turn to your clinical pharmacist. Australian and New Zealand Journal of Public Health, 40 (5), 498-498. doi: 10.1111/1753-6405.12567
Barras, Michael A., Hughes, David and Ullner, Melanie (2016). Direct oral anticoagulants: new drugs with practical problems. How can nurses help prevent patient harm?. Nursing and Health Sciences, 18 (3), 408-411. doi: 10.1111/nhs.12263
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neil (2016). Examining hospital pharmacists' goals for medication counselling within the communication accommodation theoretical framework. Research in Social and Administrative Pharmacy, 12 (5), 747-755. doi: 10.1016/j.sapharm.2015.10.008
Petrie, S., Barras, M., Lust, K., Fagermo, N., Allen, J. and Martin, J. H. (2016). Evaluation of therapeutic enoxaparin in a pregnant population at a tertiary hospital. Internal Medicine Journal, 46 (7), 826-833. doi: 10.1111/imj.13117
Pattullo, C. S., Barras, M., Tai, B., McKean, M. and Donovan, P. (2016). New oral anticoagulants: appropriateness of prescribing in real-world setting. Internal Medicine Journal, 46 (7), 812-818. doi: 10.1111/imj.13118
Dekker, Katharine R., Myers, Brooke L. and Barras, Michael A. (2016). Compliance with enoxaparin dosing and monitoring guidelines and the impact on patient length of stay: a pilot study. Therapeutic Drug Monitoring, 38 (1), 59-63. doi: 10.1097/FTD.0000000000000233
Mudge, Alison, Radnedge, Katherine, Kasper, Karen, Mullins, Robert, Adsett, Julie, Rofail, Serena, Lloyd, Sophie and Barras, Michael (2016). Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing. Australian Health Review, 40 (1), 86-91. doi: 10.1071/AH14219
Nakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P and Kennedy, Glen A (2015). A randomized trial of olanzapine and palonosetron versus infused ondansetron for the treatment of chemotherapy induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation. Blood, 126 (23), 1910-1910. doi: 10.1182/blood.v126.23.1910.1910
Chevalier, Bernadette A. M., Watson, Bernadette M., Barras, Michael A. and Cottrell, William Neill (2015). Hospital pharmacists' perceptions of medication counseling: a focus group study. Research in Social and Administrative Pharmacy, 12 (5), 756-771. doi: 10.1016/j.sapharm.2015.10.007
Lindsay, Julian N. and Barras, Michael (2015). Facing the challenges of new melanoma-targeted therapies: treatment of severe fevers associated with dabrafenib/trametinib combination therapy. Journal of Oncology Pharmacy Practice, 21 (4), 293-295. doi: 10.1177/1078155214527859
Marotti, Sally B., Barras, Michael and Kirkpatrick, Carl (2015). Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients. Therapeutic Drug Monitoring, 37 (1), 33-39. doi: 10.1097/FTD.0000000000000099
Barras, Michael (2015). Engaging pharmacists in clinical research. Australian Journal of Pharmacy, 96 (1139)
Mudge, Alison M., Barras, Michael, Adsett, Julie, Mullins, Robert W., Lloyd, Sophie and Kasper, Karen (2014). Improving Care Transitions in Individuals Frequently Admitted to the Hospital. Journal of the American Geriatrics Society, 62 (10), 1994-1996. doi: 10.1111/jgs.13033
Lindsay, Julian, Dooley, Michael, Martin, Jennifer, Fay, Michael, Kearney, Alison, Khatun, Mohsina and Barras, Michael (2014). The development and evaluation of an oncological palliative care deprescribing guideline: the 'OncPal deprescribing guideline'. Supportive Care in Cancer, 23 (1), 71-78. doi: 10.1007/s00520-014-2322-0
Lindsay, Julian, Dooley, Michael, Martin, Jennifer, Fay, Michael, Kearney, Alison and Barras, Michael (2014). Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches. Supportive Care in Cancer, 22 (4), 1113-1119. doi: 10.1007/s00520-013-2098-7
Jamsen, Kris M., McLeay, Sarah C., Barras, Michael A. and Green, Bruce (2014). Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective. Clinical Pharmacokinetics, 53 (2), 111-122. doi: 10.1007/s40262-013-0114-1
Barras, Michael, Moore, Diana, Pocock, Daniel, Sweedman, Myles, Wilkinson, Cathy, Taylor, Kerry and Morton, James (2013). Reducing the risk of harm from intravenous potassium: a multi-factorial approach in the haematology setting. Journal of Oncology Pharmacy Practice, OnlineFirst (5), 1-10. doi: 10.1177/1078155213504443
Barras, Michael (2013). Abnormal laboratory results: anti-Xa assays. Australian Prescriber, 36 (3), 98-101. doi: 10.18773/austprescr.2013.036
Iedema, Joel, Barras, Michael, Sundac, Lana and Coombes, Ian (2012). Medicinal mishap: Dabigatran - a new safe drug to replace an old poison?. Australian Prescriber, 35 (2), 64-65. doi: 10.18773/austprescr.2012.029
Martin, Jennifer, Norris, Ross and Barras, Michael (2012). Gentamicin use - more clinical outcome evidence needed. Journal of Clinical Toxicology, 2 (6), e110.1-e110.2. doi: 10.4172/2161-0495.1000e110
Martin, Jennifer, Barras, Michael, Yui, Nicholas Ah, Kirkpatrick, Carl, Kubler, Paul and Norris, Ross (2012). Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trial. Journal of Clinical Toxicology, 2 (8), 146.1-146.5. doi: 10.4172/2161-0495.1000146
Mudge, AM, Kasper, K, Clair, A, Redfern, H, Bell, JJ, Barras, MA, Dip, G and Pachana, NA (2011). Recurrent readmissions in medical patients: A prospective study. Journal of Hospital Medicine, 6 (2), 61-67. doi: 10.1002/jhm.811
Barras, Michael, Alraman, Hana, Kirkpatrick, Carl M. J., Harris, Margaret, Dakin, Carolyn, Jess, Katrina, Pilbeam, Melissa and Norris, Ross L. G. (2011). Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis. Journal of Pharmacy Practice and Research, 41 (3), 183-187. doi: 10.1002/j.2055-2335.2011.tb00857.x
Norris, Ross L., Martin, Jennifer H., Thompson, Erin, Ray, John E., Fullinfaw, Robert O., Joyce, David, Barras, Michael, Jones, Graham R. and Morris, Raymond G. (2010). Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional development. Therapeutic Drug Monitoring, 32 (5), 615-623. doi: 10.1097/FTD.0b013e3181ea3e8a
Barras, Michael A., Duffull, Stephen B., Atherton, John J. and Green, Bruce (2010). Individualized dosing of enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations. Therapeutic Drug Monitoring, 32 (4), 482-488. doi: 10.1097/FTD.0b013e3181e64846
Barras, Michael A., Kirkpatrick, Carl M.J. and Green, Bruce (2010). Current dosing of low-molecular-weight heparins does not reflect licensed product labels: An international survey. British Journal of Clinical Pharmacology, 69 (5), 520-528. doi: 10.1111/j.1365-2125.2010.03626.x
Martin, Jennifer H., Norris, Ross, Barras, Michael, Roberts, Jason, Morris, Ray, Doogue, Matthew and Jones, Graham R. D. (2010). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Clinical Biochemist Reviews, 31 (1), 21-24.
Al-Sallami, Hesham S., Barras, Michael A., Green, Bruce and Duffull, Stephen B. (2010). Routine plasma anti-Xa monitoring is required for low-molecular-weight heparins. Clinical Pharmacokinetics, 49 (9), 567-571. doi: 10.2165/11532960-000000000-00000
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2009). Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events. British Journal of Clinical Pharmacology, 68 (5), 700-711. doi: 10.1111/j.1365-2125.2009.03518.x
Gujral, Gina R., Cottrell, W. Neil and Barras, Michael (2009). Myalgia in patients on high-dose and low-to-moderate dose statin therapy. Journal of Pharmacy Practice and Research, 39 (3), 202-206. doi: 10.1002/j.2055-2335.2009.tb00453.x
Norris, R. L., Morris, R. G., Ray, J. E., Fullinfaw, R. O., Ilett, K. F., Lee, T., Martin, J., Barras, M., Thompson, E. M. and Jones, G. R. D. (2009). Preliminary results of a therapeutic drug monitoring survey in Australasia. Pathology, 41 (s1), 71-71.
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. Clinical Pharmacology & Therapeutics, 83 (6), 882-888. doi: 10.1038/sj.clpt.6100399
Barras, Michael A. and Green, Bruce (2008). Individualised vs conventional enoxaparin dosing. Journal of Pharmacy Practice and Research, 38 (1). doi: 10.1002/j.2055-2335.2008.tb00803.x
Gardner, A. Scott, Martin, James C., Martin, David T., Barras, Martin and Jenkins, 47517 (2007). Maximal torque- and power-pedaling rate relationships for elite sprint cyclists in laboratory and field tests. European Journal of Applied Physiology, 101 (3), 287-292. doi: 10.1007/s00421-007-0498-4
Toleman, J. and Barras, M. (2007). General practitioner referral letters: are we getting the full picture?. Internal Medicine Journal, 37 (7) doi: 10.1111/j.1445-5994.2007.01416.x
Roberts, Jason A., Hsu, Millie, Allen, Karen, Willis, Jennifer and Barras, Michael (2007). Pharmacists investigating adverse penicillin responses - Pilot Study. Journal of Pharmacy Practice and Research, 37 (3), 200-203. doi: 10.1002/j.2055-2335.2007.tb00744.x
Rofail, Serena and Barras, Michael A. (2006). Are patients on long-term corticosteroids receiving bone loss therapy?. Journal of Pharmacy Practice and Research, 36 (1), 29-31. doi: 10.1002/j.2055-2335.2006.tb00882.x
Sim, Lily, Barras, Michael and Cottrell, Neil (2005). Patients' understanding of drug allergy and documentation: Is there a link?. Journal of Pharmacy Practice and Research, 35 (4), 276-278. doi: 10.1002/j.2055-2335.2005.tb00362.x
O'Maley, Karen, O'Sullivan, John, Wollin, Judy, Barras, Michael and Brammer, Jillian (2005). Teaching people with Parkinson's disease about their medication. Nursing Older People, 17 (1) doi: 10.7748/nop2005.03.17.1.14.c2357
Lum, E. and Barras, M.A. (2004). Effective conference presentations. Journal of Pharmacy Practice and Research, 34, 157-158.
Conference Papers
Snoswell, Centaine L., Barras, Michael and Banks, Vivien (2019). Pharmacy technicians practicing at advanced scope, who benefits?. Medicines Management 2019: 45th SHPA Conference 2019, Gold Coast, QLD Australia, 15th November 2019.
Falconer, N., Barras, M., Abdel-Hafez, A., Radburn, S. and Cottrell, N. (2019). Prioritising hospital patients at high-risk of medication harm: development and validation of a predictive risk model. In: 14th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Stockholm, Sweden, (S35-S35). 29 June - 2 July, 2019. doi:10.1007/s00228-019-02685-2
Van Oosterom, N., Barras, M. and Winckel, K. (2019). Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity. Princess Alexandra Hospital (PAH) Health Symposium., Brisbane, QLD, Australia, 31 July 2019.
Woodruff, Gemma, Hendy, Anna, Coombes, Judith, Winckel, Karl, Hale, Andrew, Coombes, Ian and Barras, Michael (2019). Final foundation residency portfolio reviews – Feedback from a two-site review process. APSA 2019, Melbourne, Australia, 1-4 December 2019.
Banks, Vivien, Snoswell, Centaine L. and Barras, Michael (2019). Changes in service costs and time efficiencies when technicians practice at advanced scope, a systematic review. The Society of Hospital Pharmacists of Australia (SHPA) Qld Branch: 2019 Pharmacy Research Symposium, Brisbane, Australia, 26 October 2019.
George, C., Winckel, K., Barras, M., Coombes, J. and Cottrell, N. (2018). Dosing of Unfractionated Heparin in obese patients at the Princess Alexandra Hospital. Translational Research Institute Symposium, Brisbane, QLD, Australia, August 2018.
Gao, Yanhua, Hennig, Stefanie and Barras, Michael (2017). The influence of sampling time on estimated tobramycin exposure in patient with cystic fibrosis. Australian Society of Clinical Pharmacology and Toxicology national conference, Brisbane, Australia, 5 – 8 December 2017.
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2017). Identifying Clinical Pharmacist Patient Prioritisation Criteria. Australasian Pharmaceutical Science Association (APSA) and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Joint Scientific Meeting, Brisbane QLD Australia, December 2017.
Falconer, Nazanin, Barras, Michael and Cottrell, Neil (2017). Identifying inpatients at high risk of adverse drug events: Systematic review of predictive risk scores. Society of Hospital Pharmacists of Australia conference, Sydney, Australia, November 2017.
Nakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P. and Kennedy, Glen A. (2015). A Randomized Trial of Olanzapine and Palonosetron versus Infused Ondansetron for the Treatment of Chemotherapy Induced Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell Transplantation. 57th Annual Meeting of the American-Society-of-Hematology, Orlando Fl, Dec 05-08, 2015. WASHINGTON: AMER SOC HEMATOLOGY.
Cottrell, Neil, Waller, Susan, Barras, Michael, Burston, Adam, Dickie, Robyn, Groves, Michele, Kendall, Bradley and Rylands, Linda (2013). Implementation and Evaluation of an Interprofessional Curriculum. Collaborating Across Borders III (CAB III) Interprofessional Collaboration: From Concept to Preparation to Practice, Tucson, AZ, United States, 19-21 November 2011. London, United Kingdom: Informa Healthcare. doi: 10.3109/13561820.2013.761518
Norris, R. L. G., Barras, M., Alraman, H., Kirkpatrick, C., Dakin, C., Harris, M. and Jess, K. (2011). Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosis. 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Stuttgart, Germany, 2-6 October 2011. Philadelphia PA, United States: Lippincott Wiliams & Wilkins. doi: 10.1097/01.ftd.0000400651.94145.ba
Norris, Ross, Morris, Ray, Thompson, Erin, Ray, John, Barras, Michael, Jones, Graham and Martin, Jenny (2009). A survey of therapeutic drug monitoring in Australasia. 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Montréal, QC, Canada, 3-8 October 2009. New York, NY, U.S.A.: Lippincott-Raven. doi: 10.1097/FTD.0b013e3181b7997b
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). The evaluation of an individualised dosing strategy for enoxaparin. The 34th Society of Hospital Pharmacists of Australia (SHPA) National Conference, Adelaide Australia, September 2008.
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. Population Approach Group in Europe (PAGE) Conference, Marseille, France, June 2008. Leiden: Population Approach Group in Europe.
Barras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). The evaluation of an individualised dosing strategy derived from population PK modelling and simulation. Population Approach Group in Australia and New Zealand (PAGANZ) Conference, Dunedin, Otago, New Zealand, 13-15 February 2008.
Norris, R., Morris, R., Ray, J., Ilett, K.F., Fullinfaw, R., Lee, T., Martin, J., Barras, M., Thompson, E. M. and Jones, G. R. D. (2008). A survey of therapeutic drug monitoring in Australia and New Zealand. Australasian Association of Clinical Biochemists’ 45th Annual Scientific Conference, Adelaide, South Australia, 16-19 September 2008. Mt. Lawley, W.A., Australia: Australasian Association of Clinical Biochemists.
Gujral, G., Barras, M. and Cottrell, W. N. (2007). Comparison of self reported myalgia in individuals on high and low to moderate dose statin therapy. Medicines: Design to Delivery. Manly 2007 2nd Annual Conference of The Australasian Pharmaceutical Science Association, Manly, NSW, Australia, 8-11 December 2007. Australian Pharmaceutical Science Association (APSA).
Barras, M. A., Duffull, S., Atherton, J. and Green, B. (2007). A Population PKPD Model for Bleeding Events with Enoxaparin. 2007 AAPS Annual Meeting and Exposition, San Diego California, 11th-15th November, 2007.
Windsor, S.N., Barras, M. A. and Rofail, S. (2004). Milk, bread and NSAIDs: The shopping list of 2004. Measuring the impact of open sale NSAIDs.. SHPA Qld Branch Conference, Toowoomba, 16-18 July 2004. Australia: SHPA.
Thesis
Michael Barras (2009). Dose individualisation of enoxaparin. PhD Thesis, Pharmacy school, The University of Queensland.